JP2015511245A5 - - Google Patents

Download PDF

Info

Publication number
JP2015511245A5
JP2015511245A5 JP2014558849A JP2014558849A JP2015511245A5 JP 2015511245 A5 JP2015511245 A5 JP 2015511245A5 JP 2014558849 A JP2014558849 A JP 2014558849A JP 2014558849 A JP2014558849 A JP 2014558849A JP 2015511245 A5 JP2015511245 A5 JP 2015511245A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
phenyl
pyrido
pyrimidin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014558849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015511245A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/027265 external-priority patent/WO2013126656A1/en
Publication of JP2015511245A publication Critical patent/JP2015511245A/ja
Publication of JP2015511245A5 publication Critical patent/JP2015511245A5/ja
Pending legal-status Critical Current

Links

JP2014558849A 2012-02-23 2013-02-22 ピリドピリミジノン系キナーゼ阻害薬 Pending JP2015511245A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261602163P 2012-02-23 2012-02-23
US61/602,163 2012-02-23
PCT/US2013/027265 WO2013126656A1 (en) 2012-02-23 2013-02-22 Pyridopyrimidinone inhibitors of kinases

Publications (2)

Publication Number Publication Date
JP2015511245A JP2015511245A (ja) 2015-04-16
JP2015511245A5 true JP2015511245A5 (https=) 2016-06-30

Family

ID=47757712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014558849A Pending JP2015511245A (ja) 2012-02-23 2013-02-22 ピリドピリミジノン系キナーゼ阻害薬

Country Status (8)

Country Link
US (1) US9718821B2 (https=)
EP (1) EP2817308B1 (https=)
JP (1) JP2015511245A (https=)
CN (1) CN104271576A (https=)
CA (1) CA2864142A1 (https=)
ES (1) ES2606640T3 (https=)
MX (1) MX2014010176A (https=)
WO (1) WO2013126656A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201306610D0 (en) 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
GB201322602D0 (en) * 2013-12-19 2014-02-05 Almac Discovery Ltd Pharmaceutical compounds
MX382781B (es) * 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.
RU2690853C2 (ru) * 2014-09-02 2019-06-06 Пьер Фабр Медикамент Производные изохинолинона, полезные для лечения рака
GB201612095D0 (en) * 2016-07-12 2016-08-24 Almac Discovery Ltd Pharmaceutical compounds
CN109803968A (zh) * 2016-08-15 2019-05-24 辉瑞公司 吡啶并嘧啶酮cdk2/4/6抑制剂
WO2018133829A1 (zh) 2017-01-23 2018-07-26 南京明德新药研发股份有限公司 作为Wee1抑制剂的1,2-二氢-3H-吡唑[3,4-d]嘧啶-3-酮衍生物
GB201703881D0 (en) * 2017-03-10 2017-04-26 Almac Discovery Ltd Pharmaceutical compounds
US20200108074A1 (en) 2017-03-31 2020-04-09 Seattle Genetics, Inc. Combinations of chk1- and wee1- inhibitors
AU2018301837A1 (en) * 2017-07-13 2020-02-06 Syros Pharmaceuticals, Inc. Tam kinase inhibitors
CN109422754A (zh) * 2017-08-24 2019-03-05 上海迪诺医药科技有限公司 吡唑并[3,4-d]嘧啶-3-酮衍生物、其药物组合物及应用
US10807994B2 (en) 2017-10-09 2020-10-20 Nuvation Bio Inc. Heterocyclic compounds and uses thereof
WO2019074979A1 (en) 2017-10-09 2019-04-18 Girafpharma, Llc HETEROCYCLIC COMPOUNDS AND USES THEREOF
DK3712150T3 (da) 2017-11-01 2024-07-29 Wuxi Biocity Biopharmaceutics Co Ltd Makrocyklisk forbindelse, der tjener som wee1-hæmmer, og anvendelser deraf
GB201800378D0 (en) * 2018-01-10 2018-02-21 Almac Discovery Ltd Pharmaceutical compounds
AU2019348120A1 (en) * 2018-09-27 2021-05-06 Betta Pharmaceuticals Co., Ltd FGFR4 inhibitor and use thereof
JP7481336B2 (ja) 2018-10-26 2024-05-10 ウーシー・バイオシティ・バイオファーマシューティクス・カンパニー・リミテッド Wee1阻害剤としてのピリミドピラゾロン類誘導体及びその使用
CN113874016A (zh) * 2019-01-29 2021-12-31 福宏治疗公司 化合物及其用途
EP3943496A4 (en) 2019-03-22 2022-05-18 Shouyao Holdings (Beijing) Co., Ltd. Wee1 inhibitor and preparation and use thereof
CN113939296A (zh) 2019-04-09 2022-01-14 诺维逊生物股份有限公司 杂环化合物及其用途
CN113784968B (zh) 2019-04-30 2024-03-15 无锡智康弘义生物科技有限公司 Wee1抑制剂化合物的晶型及其应用
WO2021022163A2 (en) 2019-07-31 2021-02-04 Foghorn Therapeutics Inc. Compounds and uses thereof
US12528825B2 (en) 2020-01-29 2026-01-20 Foghorn Therapeutics Inc. Compounds and uses thereof
TW202144354A (zh) * 2020-03-27 2021-12-01 大陸商貝達藥業股份有限公司 Fgfr4抑制劑的鹽型、晶型及其用途
US12522607B2 (en) 2020-06-17 2026-01-13 Wigen Biomedicine Technology (shanghai) Co., Ltd. Substituted pyrazolo[3,4-d]pyrimidines as wee-1 inhibitors
US12551584B1 (en) 2020-12-07 2026-02-17 Actinium Pharmaceuticals, Inc. Lewis Y radioimmunotherapy for the treatment of cancer
AU2022265032A1 (en) 2021-04-30 2023-11-16 Wigen Biomedicine Technology (shanghai) Co., Ltd. Fused ring compound as wee-1 inhibitor, and preparation method therefor and use thereof
AU2022287033B2 (en) * 2021-06-04 2025-04-17 Aprea Therapeutics, Inc. Pyridopyrimidine derivatives useful as wee1 kinase inhibitors
CN116462687B (zh) 2022-01-18 2025-01-07 江苏天士力帝益药业有限公司 Wee1抑制剂及其制备和用途
IL315441A (en) 2022-03-07 2024-11-01 Debiopharm Int Sa Treatment methods for small cell lung cancer
CN117402162A (zh) 2022-07-13 2024-01-16 江苏天士力帝益药业有限公司 Wee1抑制剂及其制备和用途
IL326854A (en) 2023-09-14 2026-04-01 Debiopharm Int Sa Combination of WEE1 inhibitor and PKMYT1 inhibitor
TW202541810A (zh) 2023-12-22 2025-11-01 瑞士商德彪製藥國際公司 治療實體腫瘤之方法
WO2025186213A1 (en) 2024-03-04 2025-09-12 Debiopharm International S.A. Combination of a wee1 inhibitor and a topoisomerase 1 inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
PL358271A1 (pl) * 2000-03-06 2004-08-09 Warner-Lambert Company 5-alkilopirydo[2,3-D]pirymidyny jako inhibitory kinazy tyrozyny
ATE373659T1 (de) 2004-05-04 2007-10-15 Warner Lambert Co Pyrrolylsubstituierte pyrido(2,3-d)pyrimidin-7- one und derivate davon als therapeutische mittel
JP2009525292A (ja) * 2006-01-31 2009-07-09 エフ.ホフマン−ラ ロシュ アーゲー 7h−ピリド[3,4−d]ピリミジン−8−オン、それらの製造及びプロテインキナーゼ阻害剤としての使用
AR060635A1 (es) * 2006-04-27 2008-07-02 Banyu Pharma Co Ltd Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer
US8383635B2 (en) * 2008-08-12 2013-02-26 Glaxosmithkline Llc Chemical compounds
WO2010063352A1 (en) * 2008-12-01 2010-06-10 Merck Patent Gmbh 2, 5-diamino-substituted pyrido [4, 3-d] pyrimidines as autotaxin inhibitors against cancer
CA2745959A1 (en) * 2008-12-12 2010-06-17 Msd K.K. Dihydropyrimidopyrimidine derivatives
SG10201407012XA (en) * 2009-10-29 2014-11-27 Genosco Kinase inhibitors
ES2618004T3 (es) * 2012-08-07 2017-06-20 Merck Patent Gmbh Derivados de piridopirimidina como inhibidores de proteínas quinasas
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds

Similar Documents

Publication Publication Date Title
JP2015511245A5 (https=)
JP7654071B2 (ja) 複素環スピロ化合物及び使用方法
EP2945632B1 (en) Heterobicyclo-substituted-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds suitable for treatment or prevention of central nervous system disorders
ES2271221T3 (es) Derivados imidazo-pirimidina como ligandos para receptores gaba.
JP2014506929A5 (https=)
EP3883576B1 (en) Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
HRP20120105T1 (hr) Aminoheterociklički spojevi
JP2013519707A5 (https=)
ME02202B (me) Jedinjenja pirolopirimidina kao inhibitori cdk4/6
AU2021370660A1 (en) Heterocyclic spiro compounds and methods of use
BRPI1012159A2 (pt) derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo[2,3-d] pirimidinas e pirrol-3-il-pirrolo[2,3-d] pirimidinas como inibidores de janus cinase.
JP2011500774A5 (https=)
WO2015171527A1 (en) Pyrazolopyridine pyrazolopyrimidine and related compounds
JP2017531039A5 (https=)
RU2017106742A (ru) Комбинированная терапия для лечения парамиксовируса
CA2682665A1 (en) Triazinone and diazinone derivatives useful as hsp90 inhibitors
JP2013520407A5 (https=)
RU2012139830A (ru) Производные пиразолопиперидина в качестве ингибиторов nadph - оксидазы
JP2016537384A5 (https=)
JP2021512954A5 (https=)
CA3050567A1 (en) Substituted dihydroimidazopyridinediones as mknk1 and mknk2 inhibitors
JP2017513887A5 (https=)
JP2023078418A5 (https=)
RU2014109748A (ru) Морфолино-замещенные производные бициклических пиримидинмочевины или карбамата в качестве ингибиторов mtor
JP2013518823A5 (https=)